Document is current

Article History

Received: 19 February 2026

Revised: 3 June 2026

Accepted: 29 June 2026

First Online: 7 July 2026

Ethics

Competing interests: The authors declare no competing interests.

Ethics approval and consent to participate: All procedures were conducted in accordance with the Declaration of Helsinki, and all animals received humane care according to the criteria outlined in the guidelines. Animal experiments were approved by the Experimental Animal Ethics Committee of Hubei Provincial Centre for Disease Control and Prevention and were conducted in strict accordance with regulations governing animal welfare and ethics (Approval No. 202410306). The ovarian cancer tissue microarray has undergone ethical review for the use of research chips by the Ethics Committee of Shanghai Yingbeilan Biotechnology Co., Ltd., with approval number YBL202501542. Prior to sample collection, participants were thoroughly informed about the study and provided written consent. Ethical approval was granted by the Ethics Committee of the Third Affiliated Hospital of Jinzhou Medical University, with the permit number: JYDSY-IEC-KX-SQB-03.

Consent for publication: All authors have read and approved the final version of the manuscript and consent to its publication in the intended journal.